Self-Entering Therapeutics: Breaking the biologics delivery barrier
Dedicated to developing life-changing therapeutics.
What We Do
The increasingly aging population of the industrial world is leading to an increase in the number of patients suffering from neurological diseases and cancers. We develop new methods of delivering biologics into cells to drive the next generation of cell and gene therapies.
Hundreds of rare diseases await cures
Hundreds of rare diseases affecting the central nervous system or causing acute auto-immune disorders still await treatment. A quarter of all rare diseases are lethal before the age of five.
Therapies are limited by today’s technology
New cell and gene therapies are changing how we treat these diseases. However, cell therapy manufacturers are confronted with complex workflows and scalability issues. Production is currently only economically feasible at a small scale.
Our Innovative Solution
Our technology, that stems from protein domains selected by natural selection and used by microbes to invade our cells, solves the cell and gene therapy manufacturing bottlenecks. SE therapeutics enables previously unthinkable therapeutics.